Cargando…
Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development
Despite breakthroughs in antiviral therapies, chronic viral hepatitis B and C are still the major causes of liver fibrosis and hepatocellular carcinoma (HCC). Importantly, even in patients with controlled infection or viral cure, the cancer risk cannot be fully eliminated, highlighting a persisting...
Autores principales: | Virzì, Alessia, Gonzalez-Motos, Victor, Tripon, Simona, Baumert, Thomas F., Lupberger, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957739/ https://www.ncbi.nlm.nih.gov/pubmed/33801181 http://dx.doi.org/10.3390/jcm10050977 |
Ejemplares similares
-
Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences
por: Boulahtouf, Zakaria, et al.
Publicado: (2022) -
Oncogenic Signaling Induced by HCV Infection
por: Virzì, Alessia, et al.
Publicado: (2018) -
Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease
por: Roca Suarez, Armando Andres, et al.
Publicado: (2021) -
Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis
por: Zehra, Mishghan, et al.
Publicado: (2020) -
Viral manipulation of STAT3: Evade, exploit, and injure
por: Roca Suarez, Armando Andres, et al.
Publicado: (2018)